Anca D. Askanase, MD, MPH, shares potential highlights for the upcoming ACR Convergence 2024 and how excitement is building in the area of lupus therapeutics development, including two phase 3 ...

SAN DIEGO, CA—Aspirin is a viable option in patients with systemic lupus erythematosus (SLE) at risk for—or who have had—arterial thrombosis, a study presented at the 2013 ACR/ARHP Annual ...

Long-term safety and efficacy data from a continuation study of Benlysta in patients with systemic lupus erythematosus (SLE) has been released ... announced at the 2016 ACR/ARHP Annual Meeting ...

"Classification is an absolute requirement for SLE clinical trials, and for clinical and translational studies, if we want to develop new drugs," he pointed out. "ACR criteria have been great ...

Source: Adobe Stock According to the researchers, the 1997 ACR revised criteria and the SLICC 2012 criteria counted each SLE manifestation equally with one exception — the SLICC criteria counted ...

CHICAGO – The 2018 ACR/ARHP Annual Meeting featured a debate that examined whether hydroxychloroquine (HCQ) dosing should be more than 5 mg/kg in patients with systemic lupus erythematosus (SLE).

In a study published in ACR Open Rheumatology, 30 older adults with systemic lupus erythematosus (SLE) with a mean age of 71.3 years reported a sense of social isolation and a reluctance to burden ...

These data were presented in oral and poster presentations at the American College of Rheumatology (ACR) Convergence 2024, which is being held at the Walter E. Washington Convention Center in ...

The article, published in Journal of Autoimmunity, traces the history of SLE classification to 1982, when the American College of Rheumatology (ACR) released the first major set of classification ...

"Most patients with SCLE who formally meet criteria for SLE do so based on the laboratory and mucocutaneous criteria. Neither the ACR nor SLICC criteria distinguish patients with SCLE and major ...